ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 200 filers reported holding ALKERMES PLC in Q3 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $355,000 | +6.6% | 11,921 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $333,000 | +13.7% | 12,652 | +0.5% | 0.00% | +50.0% |
| Q4 2021 | $293,000 | -53.9% | 12,591 | -39.0% | 0.00% | -50.0% |
| Q3 2021 | $636,000 | +150.4% | 20,627 | +99.2% | 0.00% | +100.0% |
| Q2 2021 | $254,000 | +31.6% | 10,355 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $193,000 | -6.8% | 10,331 | -0.0% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | +3.5% | 10,334 | -0.1% | 0.00% | -33.3% |
| Q3 2020 | $200,000 | 0.0% | 10,343 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $200,000 | +32.5% | 10,343 | -1.2% | 0.00% | 0.0% |
| Q1 2020 | $151,000 | -30.4% | 10,467 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | -58.2% | 10,618 | -60.0% | 0.00% | -62.5% |
| Q3 2019 | $519,000 | +71.3% | 26,519 | +97.4% | 0.01% | +60.0% |
| Q2 2019 | $303,000 | – | 13,436 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |